Clinical Trial Update: R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating R-EPOCH with Ibrutinib for Richter Transformation in chronic lymphocytic leukemia, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Richter Transformation

Drugs mentioned

• Ibrutinib (ibrutinib)
• R-EPOCH

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Richter Transformation | Phase 2 | Status: UNKNOWN